BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9876551)

  • 1. The use of particle characteristics to elucidate mix homogeneity in binary powder blends.
    Vachon MG; Chulia D
    Drug Dev Ind Pharm; 1998 Oct; 24(10):961-71. PubMed ID: 9876551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of energy indices in estimating powder compaction functionality of mixtures in pharmaceutical tableting.
    Vachon MG; Chulia D
    Int J Pharm; 1999 Jan; 177(2):183-200. PubMed ID: 10205613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of manufacturing process on tabletting ability of powder: comparison between blending, grinding, and spray drying of two formulations made of theophylline and lactose/cellulose or Cellactose.
    Viana M; N'Dri-Stempfer B; Vachon MG; Chulia D
    Drug Dev Ind Pharm; 2002; 28(2):119-27. PubMed ID: 11926355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pharmaceutical powder blends by NIR chemical imaging.
    Ma H; Anderson CA
    J Pharm Sci; 2008 Aug; 97(8):3305-20. PubMed ID: 17948913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of the surface energy of lubricated pharmaceutical powders by inverse gas chromatography.
    Swaminathan V; Cobb J; Saracovan I
    Int J Pharm; 2006 Apr; 312(1-2):158-65. PubMed ID: 16469458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of high shear blending on alpha-lactose monohydrate.
    Bridson RH; Robbins PT; Chen Y; Westerman D; Gillham CR; Roche TC; Seville JP
    Int J Pharm; 2007 Jul; 339(1-2):84-90. PubMed ID: 17398047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of particle size on the dehydration/rehydration behaviour of lactose.
    Crisp JL; Dann SE; Edgar M; Blatchford CG
    Int J Pharm; 2010 May; 391(1-2):38-47. PubMed ID: 20156538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parameters for the formulation of physical-technical characteristics of granules of theophylline obtained by extrusion-spheronization].
    Bataille B; Rahman L; Jacob M
    Pharm Acta Helv; 1991; 66(8):233-6. PubMed ID: 1758901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A; Vetchý D; Janovská L; Krejcová K; Rabisková M
    Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex dielectric properties of microcrystalline cellulose, anhydrous lactose, and α-lactose monohydrate powders using a microwave-based open-reflection resonator sensor.
    Sung PF; Hsieh YL; Angonese K; Dunn D; King RJ; Machbitz R; Christianson A; Chappell WJ; Taylor LS; Harris MT
    J Pharm Sci; 2011 Jul; 100(7):2920-34. PubMed ID: 21328582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of load on particle size distribution of lactose-crystalline cellulose mixed powder.
    Nakamori T; Miyagishim A; Nozawa Y; Sadzuka Y; Sonobe T
    Int J Pharm; 2008 Apr; 354(1-2):255-9. PubMed ID: 18258396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process characterization of powder blending by near-infrared spectroscopy: blend end-points and beyond.
    Shi Z; Cogdill RP; Short SM; Anderson CA
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):738-45. PubMed ID: 18486399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of drug agglomerates in powder blending simulation samples by near infrared chemical imaging.
    Li W; Woldu A; Kelly R; McCool J; Bruce R; Rasmussen H; Cunningham J; Winstead D
    Int J Pharm; 2008 Feb; 350(1-2):369-73. PubMed ID: 17951017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time monitoring of powder mixing in a convective blender using non-invasive reflectance NIR spectrometry.
    Bellamy LJ; Nordon A; Littlejohn D
    Analyst; 2008 Jan; 133(1):58-64. PubMed ID: 18087614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders.
    Kwan CC; Chen YQ; Ding YL; Papadopoulos DG; Bentham AC; Ghadiri M
    Eur J Pharm Sci; 2004 Dec; 23(4-5):327-36. PubMed ID: 15567285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.